PA
PRAX icon

Perceptive Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Perceptive Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$682M Hold
2,035,986
– – 10.23% 1
2026
Q1 		$656M Buy
2,035,986
+40,000
+2% +$12.4M 12.82% 1
2025
Q4 		$588M Buy
1,995,986
+431,432
+28% +$80.3M 10.49% 1
2025
Q3 		$82.9M Buy
1,564,554
+811,633
+108% +$39.4M 2.39% 13
2025
Q2 		$31.7M Sell
752,921
-227,973
-23% -$8.68M 1.17% 24
2025
Q1 		$37.1M Sell
980,894
-348,841
-26% -$21.8M 1.31% 23
2024
Q4 		$102M Buy
1,329,735
+165,700
+14% +$12M 2.82% 10
2024
Q3 		$67M Buy
1,164,035
+413,805
+55% +$22.4M 1.42% 23
2024
Q2 		$31M Sell
750,230
-71,359
-9% -$3.37M 0.75% 39
2024
Q1 		$50.1M Buy
+821,589
New +$36.9M 0.88% 39

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Perceptive Advisors's PRAX Position: Q2 2026 in Review

Perceptive Advisors held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 2,035,986 shares worth $682M. The position accounts for 10.23% of the portfolio, ranked #1.

Perceptive Advisors first reported a position in PRAX in Q1 2024 and has held it in 10 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Perceptive Advisors held 2,035,986 shares of Praxis Precision Medicines worth $682M as of Q2 2026.
  • Perceptive Advisors left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 10.23% of Perceptive Advisors's portfolio in Q2 2026, its #1 holding.
  • Perceptive Advisors first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 10 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.